Publications by authors named "Gerald Mickisch"

Claim this Profile
[
[CARD study: relevance for the treatment of advanced prostate cancer].
Axel S Merseburger, Andreas Bannowsky, Klaus Becker, Carsten Bokemeyer, Rolf Eichenauer, Gerald Mickisch

Aktuelle Urol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human use.
Kyriaki Tzogani, Venke Skibeli, Ingunn Westgaard, Marianne Dalhus, Hege Thoresen, Gerald Mickisch

Oncologist· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice.
Lothar Bergmann, Jochaim Beck, Kathrin Bothe, Olaf A Brinkmann, Stephan Buse, Gerald Mickisch

Oncol Res Treat· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial.
Paul C M S Verhagen, Mark F Wildhagen, Annet M Verkerk, Egils Vjaters, Hembo Pagi, Gerald H J Mickisch

World J Urol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy.
Gerald Hj Mickisch, Björn Schwander, Bernard Escudier, Joaquim Bellmunt, José P Maroto

Clinicoecon Outcomes Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle-invasive urothelial carcinoma of the bladder.
S Bruce Malkowicz, Hendrik van Poppel, Gerald Mickisch, Vito Pansadoro, Joachim Thüroff

Urology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of surgery and immunotherapy in metastatic renal cell carcinoma.
Gerald H Mickisch, Roland H Mattes

World J Urol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
Nina Aass, Pieter H M De Mulder, Gerald H J Mickisch, Peter Mulders, Allan T van Oosterom

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma.
Sophie D Fosså, Gerald H J Mickisch, Pieter H M De Mulder, Simon Horenblas, Allan T van Oosterom

Cancer· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality treatment of metastatic renal cell carcinoma.
Gerald H Mickisch

Expert Rev Anticancer Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis